Your browser doesn't support javascript.
loading
Human thymopoiesis produces polyspecific CD8+ α/ß T cells responding to multiple viral antigens.
Quiniou, Valentin; Barennes, Pierre; Mhanna, Vanessa; Stys, Paul; Vantomme, Helene; Zhou, Zhicheng; Martina, Federica; Coatnoan, Nicolas; Barbie, Michele; Pham, Hang-Phuong; Clémenceau, Béatrice; Vie, Henri; Shugay, Mikhail; Six, Adrien; Brandao, Barbara; Mallone, Roberto; Mariotti-Ferrandiz, Encarnita; Klatzmann, David.
Afiliação
  • Quiniou V; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
  • Barennes P; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Mhanna V; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
  • Stys P; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Vantomme H; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
  • Zhou Z; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Martina F; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
  • Coatnoan N; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
  • Barbie M; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Pham HP; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Clémenceau B; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Vie H; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Shugay M; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Six A; ILTOO pharma, Statistical department, Paris, France.
  • Brandao B; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
  • Mallone R; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
  • Mariotti-Ferrandiz E; Center of Life Sciences, Skoltech, Moscow, Russian Federation.
  • Klatzmann D; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
Elife ; 122023 03 30.
Article em En | MEDLINE | ID: mdl-36995951
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Antígenos Virais Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Antígenos Virais Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido